NRD to Predict COPD Exacerbations at Home

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

February 13, 2018

Primary Completion Date

June 6, 2019

Study Completion Date

June 6, 2019

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DIAGNOSTIC_TEST

Neural respiratory drive measurement

"Neural respiratory drive (NRD) has been validated as an objective physiological biomarker in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Change in NRD during hospital admission has been demonstrated to be a marker of physician-defined clinical deterioration. NRD is a non-invasive measurement that involves skin preparation with a gel and alcohol wipe before placing 3 surface electrodes on the chest wall and collar bone to perform electromyography (EMG) of parasternal muscles. Electrodes are connected to an automated EMG analysis system to derive a measurement of NRD. Measurements take approximately 10 minutes with subject being monitored during normal (tidal) breathing and performing maximal sniff manoeuvres."

Trial Locations (1)

SE1 7EH

Guys and St Thomas NHS Foundation Trust, London

All Listed Sponsors
lead

Guy's and St Thomas' NHS Foundation Trust

OTHER

NCT03443505 - NRD to Predict COPD Exacerbations at Home | Biotech Hunter | Biotech Hunter